Hopital Saint Andre CHU De Bordeaux; Dermatologie

Bordeaux 33075

0 studies enrolling now · 3 studies all time

What they study most

Advanced BRAFV600 Wild-type Melanoma, Atopic Dermatitis, Basal Cell Carcinoma

Studies at this site

• A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma — Stopped early
• A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis — Completed
• A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas — Completed